Two Sigma Securities’s Allogene Therapeutics ALLO Stock Holding History
Bought
Maintained
Sold
Other funds holding ALLO
Two Sigma Securities's ALLO Position: Q3 2026 in Review
Two Sigma Securities opened a new position in Allogene Therapeutics (ALLO) in Q3 2026: 81,044 shares worth $130K. The stake represents 0.01% of the portfolio and ranks #1274 among its holdings. This is a return to the name: Two Sigma Securities previously reported a position in ALLO as recently as Q4 2025.
Two Sigma Securities first reported a position in ALLO in Q2 2025 and has held it in 4 quarters since. 198 funds tracked by Wall St. Rank hold ALLO as of Q3 2026.
- Two Sigma Securities held 81,044 shares of Allogene Therapeutics worth $130K as of Q3 2026.
- Allogene Therapeutics was a new Two Sigma Securities position in Q3 2026.
- Allogene Therapeutics made up 0.01% of Two Sigma Securities's portfolio in Q3 2026, its #1274 holding.
- Two Sigma Securities first reported a position in Allogene Therapeutics in Q2 2025 and has held it in 4 quarters since.
- 198 funds tracked by Wall St. Rank held Allogene Therapeutics as of Q3 2026.
Based on Two Sigma Securities's 13F filing for Q3 2026, filed 16 Nov 2026.